双黄升白方对糖尿病合并肿瘤化疗患者癌因性疲乏及生活质量的影响

Puntos clave

• The study aims to evaluate the clinical effects of Dual Yellow Ascending White Decoction in alleviating cancer-related fatigue and improving the quality of life in diabetic patients with malignant tumors receiving chemotherapy.
• 250 diabetic patients with malignant tumors undergoing chemotherapy enrolled from a hospital between July 2019 to December 2024.
• Randomized controlled trial design with hidden envelope method for group allocation.
• Control group received conventional treatment with Lixuan tablets; the experimental group received additional Dual Yellow Ascending White Decoction.
• Comparison of traditional Chinese medicine symptom scores, Piper fatigue scale, Karnofsky Performance Status (KPS), and blood parameters between groups.
• Both groups showed reductions in total scores for major and minor symptoms of traditional Chinese medicine and fatigue scales, with greater improvement in the experimental group.
• KPS scores increased in both groups, but the experimental group showed a higher overall effective rate of 64.00% versus 48.00% in the control group (P<0.05).
• No significant differences in adverse reaction rates were observed (P>0.05).